These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9280469)

  • 1. [Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Reznikov AIu; Galygo DS; Bartashevich VV
    Biull Eksp Biol Med; 1996 Dec; 122(12):665-8. PubMed ID: 9280469
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Bartashevich VV; Popov PB; Sirotenko DV; Boldin VB
    Biull Eksp Biol Med; 1998 Jun; 125(6):641-6. PubMed ID: 9693756
    [No Abstract]   [Full Text] [Related]  

  • 4. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
    Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmic effects of morlincain].
    Zhang YL; Rui YC; Tu SZ
    Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):417-20. PubMed ID: 3450178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological research on bonnecor and its metabolites].
    Poppe H; Heer S; Barch R
    Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New pharmacodynamic effects of gidazepam and befol in patients with cardiac arrhythmias].
    Skibitskiĭ VV; Kanorskiĭ SG
    Eksp Klin Farmakol; 1993; 56(5):23-7. PubMed ID: 7906171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
    Berdiaev SIu; Marko R; Kelemen K; Darinskiĭ NV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):16-9. PubMed ID: 3531669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study of bonnecor in the treatment of heart rhythm disorders in patients with ischemic heart disease].
    Gorshkov VA; Solodukhina IS; Kesarev GV; Kurakina TI; Solov'eva FV
    Sov Med; 1991; (7):45-7. PubMed ID: 1948344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
    Gorbunova VV; Gorbunov NP
    Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the new anti-arrhythmia preparation Bonnecor on the hemodynamics and activity of the ischemic heart].
    Tolmacheva EA; Chichkanov GG; Matsievskiĭ DD
    Biull Eksp Biol Med; 1989 May; 107(5):588-90. PubMed ID: 2736295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia properties of marcaine].
    Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
    Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of bonnecor in ischemic heart disease].
    Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
    Sov Med; 1990; (6):72-4. PubMed ID: 2396129
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative anti-arrhythmia effectiveness of activators of body stress-limiting systems in patients with arrhythmia].
    Meerson FZ; Skibitskiĭ VV
    Kardiologiia; 1992 Apr; 32(4):25-30. PubMed ID: 1328745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment].
    Galenko-Iaroshevskiĭ PA; Tikhonov AV
    Farmakol Toksikol; 1985; 48(2):64-8. PubMed ID: 3996574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.